4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001415889-25-007075
Options or other derivatives
- Chief Financial Officer acquired 265,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Carulli Michael Chief Financial Officer | 2025-03-03 | Grant or award · Employee Stock Option (right to buy) | +265,000 | 265,000 | D | ||
Loading xslF345X05/form4-03052025_110309.xml…